National Comprehensive Cancer Network

About NCCN

NCCN Flash Update: NCCN Guidelines® & NCCN Compendium® Updated

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Non-Small Cell Lung Cancer. These NCCN Guidelines® are currently available as Version 6.2017.

  • ALK Rearrangement Positive Metastatic Non-Small Cell Lung Cancer (NSCL-21)
    • Asymptomatic progression; Symptomatic progression - brain or multiple systemic lesions: Brigatinib added as an option for subsequent therapy (category 2A).
    • Footnote "rr" modified: Patients who are intolerant to crizotinib may be switched to ceritinib, alectinib, or brigatinib.
    • Footnote "tt" added: Alectinib or brigatinib are treatment options for patients with ALK-positive metastatic NSCLC that have progressed on crizotinib.
       
  • The Discussion section has been updated to reflect the changes in the guidelines. (MS-1)

*For your reference, the previous update (Version 5.2017) to the NCCN Guidelines for Non-Small Cell Lung Cancer, published on March 16, 2017, is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

 

NCCN has published updates to the NCCN Guidelines for Adult Cancer Pain. These NCCN Guidelines are currently available as Version 2.2017.

  • The Discussion section has been updated to reflect the changes in the guidelines. (MS-1)

*For your reference, the previous update (Version 1.2017) to the NCCN Guidelines for Adult Cancer Pain, published on March 20, 2017 is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf

 

For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Compendium®, the NCCN Biomarkers Compendium®, the NCCN Chemotherapy Order Templates (NCCN Templates®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.

To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.

Free NCCN Guidelines apps for iPhone, iPad, and Android smartphones & tablets are now available! Visit NCCN.org/apps

About NCCN Flash Updates™ 
NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium, and other NCCN Content. 

Subscribe to NCCN Flash Updates™ 

National Comprehensive Cancer Network® (NCCN®)
275 Commerce Drive, Suite 300
Fort Washington, PA 19034
Telephone: +1 215.690.0300 Fax: +1 215.690.0280 

Access information on permissions and licensing of NCCN Content  

© 2017 National Comprehensive Cancer Network. All Rights Reserved.